🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A 36-month Analysis of the Clinical Performance of Individualized CAD/CAM-produced Dental Implants: a Cohort Study

Recruitingn/aAges any - anyAllUniversity of Sao Paulo
NCT06576284 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this prospective cohort study is to evaluate the clinical performance of a new generation of customized CAD/CAM pre-fabricated root-analog dental implants over a 36-month period. The main questions it aims to answer are: 1. Are these novel implants safe, effective, and clinically viable for 36 months? 2. Do these drilling-free implants result in better post-operative outcomes compared to traditional implant techniques? Twelve patients receiving these customized implants immediately after tooth extraction will undergo clinical and radiographic examinations at 12, 24, and 36 months after prosthesis installation. The study will assess peri-implant tissue health, post-operative comfort, bone preservation, tissue integration, and implant survival rates.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Received a personalized dental implant using the iDENTICAL Dental Implant System during the previous interventional phase; * Completed the 12-month follow-up period after implant placement in the previous interventional phase; * Available for follow-up evaluations during the 36 months of the observational study. Exclusion Criteria: * Occurrence of serious complications (implant loss, infection, etc.) during the previous interventional phase; * Development of uncontrolled medical conditions during the follow-up period; * Inability to attend scheduled follow-up visits; * Refusal to participate in the observational study.
💊

What it tests

  • Not listed
📍

Where

1 site
School of Dentistry - University of São Paulo
São Paulo, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy